CHOLESTEROL HOMEOSTASIS IN THE INBRED MOUSE.
CHOLESTEROL HOMEOSTASIS IN THE INBRED MOUSE.
批准号:
7487994
负责人:
DAVID Q WANG
金额:
$34.75万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-09-01 至 2010-08-31
关键词:
ATP-Binding Cassette TransportersAccountingAttentionBile fluidBiliaryBiliary calculiBiochemicalCholecystokininCholecystokinin ReceptorCholelithiasisCholesterolCholesterol HomeostasisChromosomes, Human, Pair 10DataDiagnosisDisruptionEarly DiagnosisEstradiolEstrogen ReceptorsEstrogensFemaleGallbladderGenesGeneticGenetic TechniquesGenomeGenotypeGonadal Steroid HormonesHepaticHumanInbred MouseInbred StrainLaboratoriesLeadLiverLocalizedMammalsMapsMetabolismMolecular GeneticsMouse StrainsMusMutationNamesPathway interactionsPhenotypePlayPopulationPredispositionPreventionPrevention approachPubertyQuantitative Trait LociRateRiskRoleSusceptibility GeneTestingTetragastrinWomanWorkbile saltschild bearingmennovel strategiesreceptorresponsetrait
中文摘要
在所有被研究的人群中,胆固醇结石在女性中比男性更常见。这
女性和男性之间的差异从青春期开始,一直持续到生育阶段,
将注意力集中在女性性激素的影响上。患胆固醇结石的风险增加
女性与男性的差异与肝脏代谢胆固醇对雌激素的反应方式不同有关。我们
利用自交系AKR/J与A/J杂交的数量性状座位(QTL)分析
确定这些菌株所拥有的胆结石易感基因的子集。值得注意的是,一个新的QTL是
检测到并命名了定位于小鼠10号染色体的Lith5。我们的分子和遗传数据支持
编码雌激素受体O_2的ER_z基因作为LITH5的主要基因的候选,以及
在17[3-雌二醇(E2)诱导的胆结石中,肝脏ERA而不是ER[3]起着关键作用。然而,
鉴定Lith5的致石作用仍然是一个巨大的挑战。这份续期申请是
重点通过系统研究Lith5的病理生理学和生物学特性来确定其致石作用。
某些“制造”小鼠品系的生化功能,如ERO_(-/-)、ATP结合盒
转运蛋白GS/G8(ABCG5/G8)(-/-)和CCK-1R(-/-)小鼠。申请人
建议(I)研究靶向破坏小鼠Lith5/era基因是否会降低易感性
胆固醇结石形成;(Ii)检验E2-Lith5/ERO_-ABCG5/G8途径是
胆汁胆固醇高分泌;(Iii)测定Lith5_RC_in引起的改变
导致胆汁胆固醇过饱和的肝脏胆固醇和胆盐代谢;以及(Iv)探索
E_2-Lith5/ERA-CCK-1R通路是否诱导胆固醇结石时的胆囊动力减退
队形。这项工作应该为识别人类的主要Lith基因铺平道路,进而,
应导致早期诊断该特征的战略和合理的预防方法。
英文摘要
Cholesterol gallstones are more common in women than men in every population that has been studied. This
difference between women and men begins during puberty and continues through the childbearing years,
focusing attention upon the effects of female sex hormones. The increased risk of cholesterol gallstones in
women vs. men is related to differences in how the liver metabolizes cholesterol in response to estrogen. We
employed quantitative trait locus (QTL) analyses of an intercross between inbred strains AKR/J and A/J to
determine the subset of gallstone susceptibility genes these strains possess. Significantly, a new QTL is
detected and named Lith5 that is mapped to mouse chromosome 10. Our molecular and genetic data support
the candidacy of the ER_z gene, encoding estrogen receptor o_, as a major gene underlying Lith5, as well as
the hepatic ERa, but not ER[3, plays a critical role in 17[3-estradiol (E2)-induced gallstones. However, the
identification of lithogenic effects of Lith5 remains a significant challenge. This renewal application is
focused on identifying the lithogenic effects of Lith5 by systematically studying its pathophysiological and
biochemical functions in some "manufactured" mouse strains such as ERo_ (-/-), ATP-binding cassette
transporters GS/G8 (ABCG5/G8) (-/-), and cholecystokinin-1 receptor (CCK-1R) (-/-) mice. The applicant
proposes to (i) investigate whether targeted disruption of the murine Lith5/Era gene decreases susceptibility
to cholesterol gallstone formation; (ii) test the hypothesis that E2-Lith5/ERo_-ABCG5/G8 pathway is
responsible for biliary cholesterol hypersecretion; (iii) determine the alterations induced by Lith5_Rc_ in
hepatic cholesterol and bile salt metabolism that account for cholesterol supersaturated bile; and (iv) explore
whether E2-Lith5/ERa-CCK-1R pathway induces gallbladder hypomotility during cholesterol gallstone
formation. This work should pave the way for identifying the major Lith genes in humans, which, in turn,
should lead to strategies for early diagnosis of the trait and rational approaches to prevention.
期刊论文(36)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1155/2012/304292
发表时间:
2012
期刊:
Journal of lipids
影响因子:
5.3
作者:
[Garruti G, Wang HH, Bonfrate L, de Bari O, Wang DQ, Portincasa P]
通讯作者:
Portincasa P
Biliary proteins and their redox status changes in gallstone patients.
胆结石患者的胆汁蛋白及其氧化还原状态的变化。
DOI:
10.1111/j.1365-2362.2009.02187.x
发表时间:
2009
期刊:
European journal of clinical investigation
影响因子:
5.5
作者:
[Grattagliano,I, Wang,DQ-H, DiCiaula,A, Diogo,CV, Palasciano,G, Portincasa,P]
通讯作者:
Portincasa,P
DOI:
10.1186/1471-230x-8-7
发表时间:
2008-02-27
期刊:
BMC gastroenterology
影响因子:
2.4
作者:
[Di Ciaula A, Covelli M, Berardino M, Wang DQ, Lapadula G, Palasciano G, Portincasa P]
通讯作者:
Portincasa P
Transgenic overexpression of Abcb11 enhances biliary bile salt outputs, but does not affect cholesterol cholelithogenesis in mice.
Abcb11 的转基因过表达可增强小鼠胆汁胆汁盐的输出,但不影响胆固醇胆石生成。
DOI:
10.1111/j.1365-2362.2010.02300.x
发表时间:
2010
期刊:
European journal of clinical investigation
影响因子:
5.5
作者:
[Wang,HelenH, Lammert,Frank, Schmitz,Anne, Wang,DavidQ-H]
通讯作者:
Wang,DavidQ-H
DOI:
10.1016/j.bbalip.2009.10.003
发表时间:
2010-02
期刊:
Biochimica et biophysica acta
影响因子:
--
作者:
[Wang HH, Portincasa P, Liu M, Tso P, Samuelson LC, Wang DQ]
通讯作者:
Wang DQ
共 16 条
GPR30 and hepatic cholesterol metabolism
-
批准号:10213710
-
项目类别:
-
资助金额:$46.89万
-
财政年份:2020
-
负责人:DAVID Q WANG
-
依托单位:
Apolipoprotein A5 and Gallstone Formation
-
批准号:9914001
-
项目类别:
-
资助金额:$37.58万
-
财政年份:2018
-
负责人:DAVID Q WANG
-
依托单位:
Gene therapy of alcoholic liver disease
-
批准号:9547735
-
项目类别:
-
资助金额:$9.55万
-
财政年份:2017
-
负责人:DAVID Q WANG
-
依托单位:
Gene therapy of alcoholic liver disease
-
批准号:9297754
-
项目类别:
-
资助金额:$24.01万
-
财政年份:2017
-
负责人:DAVID Q WANG
-
依托单位:
GPR30 and Hepatic Cholesterol Homeostasis
-
批准号:8943150
-
项目类别:
-
资助金额:$34.09万
-
财政年份:2015
-
负责人:DAVID Q WANG
-
依托单位:
GPR30 and Hepatic Cholesterol Homeostasis
-
批准号:9302754
-
项目类别:
-
资助金额:$33.47万
-
财政年份:2015
-
负责人:DAVID Q WANG
-
依托单位:
GPR30 and Hepatic Cholesterol Homeostasis
-
批准号:9857099
-
项目类别:
-
资助金额:$0.62万
-
财政年份:2015
-
负责人:DAVID Q WANG
-
依托单位:
Role of GPR30 in Hepatic Lipid Metabolism
-
批准号:8917341
-
项目类别:
-
资助金额:$18.94万
-
财政年份:2014
-
负责人:DAVID Q WANG
-
依托单位:
The Role of Dysfunctional CCK-1R in Cholelithogenesis
-
批准号:7369647
-
项目类别:
-
资助金额:$36.13万
-
财政年份:2008
-
负责人:DAVID Q WANG
-
依托单位:
The Role of Dysfunctional CCK-1R in Cholelithogenesis
-
批准号:8018566
-
项目类别:
-
资助金额:$31.24万
-
财政年份:2008
-
负责人:DAVID Q WANG
-
依托单位:
The Role of Dysfunctional CCK-1R in Cholelithogenesis
-
批准号:7556320
-
项目类别:
-
资助金额:$36.13万
-
财政年份:2008
-
负责人:DAVID Q WANG
-
依托单位:
CHOLESTEROL HOMEOSTASIS IN THE INBRED MOUSE.
-
批准号:6823623
-
项目类别:
-
资助金额:$37.4万
-
财政年份:1999
-
负责人:DAVID Q WANG
-
依托单位:
CHOLESTEROL HOMEOSTASIS IN THE INBRED MOUSE
-
批准号:2901952
-
项目类别:
-
资助金额:$19.44万
-
财政年份:1999
-
负责人:DAVID Q WANG
-
依托单位:
CHOLESTEROL HOMEOSTASIS IN THE INBRED MOUSE
-
批准号:6630517
-
项目类别:
-
资助金额:$25.65万
-
财政年份:1999
-
负责人:DAVID Q WANG
-
依托单位:
CHOLESTEROL HOMEOSTASIS IN THE INBRED MOUSE.
-
批准号:7283709
-
项目类别:
-
资助金额:$35.46万
-
财政年份:1999
-
负责人:DAVID Q WANG
-
依托单位:
CHOLESTEROL HOMEOSTASIS IN THE INBRED MOUSE
-
批准号:6523708
-
项目类别:
-
资助金额:$24.91万
-
财政年份:1999
-
负责人:DAVID Q WANG
-
依托单位:
CHOLESTEROL HOMEOSTASIS IN THE INBRED MOUSE.
-
批准号:6948276
-
项目类别:
-
资助金额:$37.4万
-
财政年份:1999
-
负责人:DAVID Q WANG
-
依托单位:
CHOLESTEROL HOMEOSTASIS IN THE INBRED MOUSE
-
批准号:6500070
-
项目类别:
-
资助金额:$6.86万
-
财政年份:1999
-
负责人:DAVID Q WANG
-
依托单位:
CHOLESTEROL HOMEOSTASIS IN THE INBRED MOUSE.
-
批准号:7109313
-
项目类别:
-
资助金额:$36.52万
-
财政年份:1999
-
负责人:DAVID Q WANG
-
依托单位:
CHOLESTEROL HOMEOSTASIS IN THE INBRED MOUSE
-
批准号:6178044
-
项目类别:
-
资助金额:$13.16万
-
财政年份:1999
-
负责人:DAVID Q WANG
-
依托单位:
海外基金